Against a backdrop of major revisions to the EU “Pharma Package” to promote access to new medicines, and U.S. moves towards most favored nation (MFN) drug pricing, cross-border deals endure and must take these reforms into account. Join Geoffrey Lin and Lincoln Tsang as they discuss and share valuable insights on the effect of U.S. MFN pricing developments and EU pharmaceutical legislation on deal making. This webinar will:
- Examine the current landscape of MFN drug pricing and EU pharmaceutical regulation
- Highlight recent developments, and
- Discuss the future outlook for cross-border deal making and key questions and tools to employ in deal-making efforts
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.